Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation

• Stephanie K. Guest ,

  Contributed equally to this work with: Stephanie K. Guest, Ricardo Ribas

  Affiliation The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom

  ⨯
• Ricardo Ribas ,

  Contributed equally to this work with: Stephanie K. Guest, Ricardo Ribas

  Affiliation The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom

  ⨯
• Sunil Pancholi,

  Affiliation The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom

  ⨯
• Joanna Nikitorowicz-Buniak,

  Affiliation The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom

  ⨯
• Nikiana Simigdala,

  Affiliation The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom

  ⨯
• Mitch Dowsett,

  Affiliations The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom, Royal Marsden Hospital, London, United Kingdom

  ⨯
• Stephen R. Johnston,

  Affiliation Royal Marsden Hospital, London, United Kingdom

  ⨯
• Lesley-Ann Martin

  * E-mail: lesley-ann.martin@icr.ac.uk

  Affiliation The Breast Cancer Now and Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom

  ⨯